For the Inventor, By the Inventor

Enter assignee name

Morgantown, WV, United States of America

Mylan Pharmaceuticals Inc.

USPTO Granted Patents = 25

% Expired Patents = 24.0

CIPO Patents = 5

EPO Patents = 4

Trademarks = 24

Forward Citations = 255

Loading Chart...

Loading Chart...

31 inventors (with patents filed for the assignee):

Boyong Li (4 out of 21 patents)

Dwight D Hanshew, Jr (4 out of 4 patents)

David John Wargo (4 out of 5 patents)

4. Imtiaz A Chaudry (3 out of 27 patents)

5. Kenneth James Miller, Ii (3 out of 10 patents)

6. Paul H Bonner (3 out of 3 patents)

7. Cheryl D Blume (3 out of 3 patents)

8. Partha S Banerjee (2 out of 16 patents)

9. Stephen Pham (2 out of 20 patents)

10. Kristin Jackson (2 out of 5 patents)

11. Mummini Aruna Murty (2 out of 3 patents)

12. Sharad K Govil (2 out of 8 patents)

13. Kuljit Singh Bhatia (2 out of 2 patents)

14. Kerry R Benson (2 out of 2 patents)

15. Daniel A Snider (2 out of 2 patents)

Core Competencies:

Bronchodilators

Transdermal Delivery

Controlled Release

Pharmaceutical Compositions

Drug Formulations

Nitrosamine Inhibitor

G-CSF Purification

Budesonide

Fentanyl Adhesives

Thyroxine Stability

Phenytoin Sodium

Diuretic Combinations

25 patents: Sort by Forward Citations

1. 12678420 - Solid oral pharmaceutical compositions including alkyl 3,4,5-trihydroxybenzoate as a nitrosamine inhibitor (2026-07-14),

2. 10844103 - Method for the purification of G-CSF (2020-11-24),

3. 9730890 - Bronchodilating beta-agonist compositions and methods (2017-08-15),

4. 9205062 - Transdermal systems containing multilayer adhesive matrices to modify drug delivery (2015-12-08),

5. 9198877 - Transdermal systems containing multilayer adhesive matrices to modify drug delivery (2015-12-01),

6. 8962036 - Disintegrable formulations of lanthanum carbonate (2015-02-24),

7. 8945616 - Controlled release budesonide minitablets (2015-02-03),

8. 8945615 - Controlled release budesonide minitablets (2015-02-03),

9. 8912174 - Formulations and methods for treating rhinosinusitis (2014-12-16),

10. 8486452 - Stabilized tolterodine tartrate formulations (2013-07-16),

11. 8449907 - Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl (2013-05-28),

12. 8114912 - Bronchodilating β-agonist compositions and methods (2012-02-14),

13. 8110226 - Drug formulations having inert sealed cores (2012-02-07),

14. 7556823 - Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl (2009-07-07),

15. 7195779 - Storage stable thyroxine active drug formulations and methods for their production (2007-03-27),

Company Overview

Mylan Pharmaceuticals Inc., headquartered in Morgantown, West Virginia, is a global healthcare company specializing in the development and manufacturing of generic and specialty pharmaceuticals. The organization is committed to providing access to high-quality medicines across various therapeutic areas, including oncology, infectious diseases, and cardiovascular health. Mylan leverages advanced technologies and extensive research capabilities to innovate and enhance its product offerings, ensuring they meet the diverse needs of patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

25 Patents

#2 in Morgantown, WV

#14 in West Virginia

#13,364 in US

#25,710 in the World

Morgantown, WV, United States of America

Mylan Pharmaceuticals Inc.

Forward Citations = 255

31 inventors:

Boyong Li (4 out of 21 patents)

Dwight D Hanshew, Jr (4 out of 4 patents)

David John Wargo (4 out of 5 patents)

4. Imtiaz A Chaudry (3 out of 27 patents)

5. Kenneth James Miller, Ii (3 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Mylan Pharmaceuticals Inc.. Retrieved from https://idiyas.com/company/mylan-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…